Trevena Inc (STU:6T4) Stock Price, Trades & News

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Financial Strength

	Name	Current	Vs Industry		Vs History

Growth Rank

	Name	Current	Vs Industry		Vs History

Momentum Rank

	Name	Current	Vs Industry		Vs History

Liquidity Ratio

	Name	Current	Vs Industry		Vs History

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History

Profitability Rank

	Name	Current	Vs Industry		Vs History
	FCF Margin %	-4976.8
	OCF Margin %	-4976.8

GF Value Rank

2/10

	Name	Current	Vs Industry		Vs History
	EV-to-Forward-Revenue	8.57

Financials (Next Earnings Date:2026-07-20 Est.)

Annual Quarterly TTM

STU:6T4's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Trevena Inc Executives

Details

GF Value™

STU:6T4

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected issues with 6T4. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	0.5
	EPS (TTM) (€)	-44.836
	Beta	1.2144
	3-Year Sharpe Ratio	-1.15
	3-Year Sortino Ratio	-1.16
	Volatility %	-
	14-Day RSI	-
	14-Day ATR (€)	-
	20-Day SMA (€)	4.335
	12-1 Month Momentum %	-
	52-Week Range (€)	4.335 - 4.335
	Shares Outstanding (Mil)	0.86

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	0
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Trevena Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Trevena Inc Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings results for 2026	2026-11-13	In 116 days
Second quarter earnings results for 2026	2026-08-14	In 25 days
First quarter earnings results for 2026	2026-07-20	4.34 (+0.00%)
Third quarter earnings results for 2024	2024-11-07	4.34 (+0.00%)
0.04:1 Stock Split	2024-08-13	4.34 (+0.00%)
Second quarter earnings results for 2024	2024-08-08	4.51 (+1.35%)
0.04:1 Stock Split	2022-11-10	80.38 (-24.35%)

Show

Entries

Trevena Inc Frequently Asked Questions

What is Trevena Inc(STU:6T4)'s stock price today?

The current price of STU:6T4 is €4.34. The 52 week high of STU:6T4 is €4.34 and 52 week low is €4.34.

When is next earnings date of Trevena Inc(STU:6T4)?

The next earnings date of Trevena Inc(STU:6T4) is 2026-07-20 Est..

Does Trevena Inc(STU:6T4) pay dividends? If so, how much?

Trevena Inc(STU:6T4) does not pay dividend.

Press Release

	Subject	Date
	Thinking about buying stock in CymaBay Therapeutics, Trevena Inc, Co-Diagnostics, Plug Power, or Aurora Cannabis?	2020-08-03
	Thinking about buying stock in Sorrento Therapeutics, Chesapeake Energy Corp, Trevena, Delta Air Lines, or Royal Caribbean Cruises?	2020-05-18
	TREVENA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN	2019-07-19
	TRVN LOSS NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Trevena, Inc.; Important Dec. 10 Deadline - TRVN	2018-12-04
	Johnson Fistel Files Class Action Suit Against Trevena, Inc.	2018-11-16
	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Trevena, Inc. of Class Action Lawsuit and Upcoming Deadline - TRVN	2018-11-07
	LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Trevena, Inc. To Contact The Firm	2018-11-07
	Investor Alert: Kaplan Fox Announces Investigation Of Trevena Inc.	2018-11-02
	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Trevena, Inc. (TRVN) & Lead Plaintiff Deadline: December 10, 2018	2018-10-12
	Trevena Class Action Lawsuit: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Trevena, Inc. - TRVN	2018-10-11

10/Page

Articles on Trevena Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.